SK Biopharmaceuticals Co., Ltd.

KRX:326030.KS

110300 (KRW) • At close January 15, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) KRW.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Omzet 136,601.569133,995.444113,974.705126,755.84890,338.27177,013.07860,784.35962,767.0488,834.33853,432.88341,144.859230,735.78523,950.60823,969.367139,988.7716,082.7763,923.0482,065.4183,927.784199.07481.6596,508.23117,063.454
Kosten van de omzet 16,532.3988,745.03615,139.65317,299.3016,795.7119,373.8683,938.22210,563.32913,238.5547,954.9246,011.32716,185.5482,219.7052,084.4611,846.279430.582331.732810.193401.503441.1970730
Brutowinst 120,069.171125,250.40898,835.052109,456.54783,542.5667,639.2156,846.13752,203.71275,595.78445,477.9635,133.531214,550.23621,730.90221,884.905138,142.49115,652.1943,591.3161,255.2253,526.281-242.12381.6596,435.23117,063.454
Brutowinstmarge 0.8790.9350.8670.8640.9250.8780.9350.8320.8510.8510.8540.930.9070.9130.9870.9730.9150.6080.898-1.21610.9891
Onderzoek- en ontwikkelingskosten 043,553.52135,674.56438,631.838,765.36231,473.93828,258.03634,722.94231,044.25231,694.76525,354.78428,128.929,578.46830,810.34826,008.61931,183.29528,882.86521,056.26127,318.96478,500.91227,680.19935,118.66334,912.988
Algemene en administratieve kosten 100,725.24799,204.85191,733.25916,605.84594,254.6186,575.26611,949.76717,862.67917,169.2916,017.69711,385.75816,150.1412,233.91412,355.1939,222.41212,992.57712,028.60812,381.80616,298.606-1,557.3771,944.9746,714.0911,959.314
Verkoop- en marketingkosten 0-47,882.555-40,524.938,796.3089,165.19410,793.80311,386.56718,410.32910,538.59910,097.00110,840.15814,220.5778,090.16611,167.3946,361.4657,265.2656,340.8725,497.2296,257.46874.853252.163108.14653.573
Verkoop-, algemene en administratieve kosten 100,725.24751,322.29651,208.32955,064.92494,254.6186,575.26623,336.33436,273.00827,707.88926,114.69822,225.91630,370.71720,324.0823,522.58715,583.87720,257.84218,369.4817,879.03522,556.074-1,482.5242,197.1376,822.2372,012.887
Overige kosten 030,428.464-1,697.343-977.665-188,509.22-173,150.53327,908.01525,828.42126,091.07627,740.55224,690.712-4.085-13.538-473.556-3.264-14.95-495.4010.0152.16261.657185.80647.92777.74
Bedrijfskosten 100,725.24796,052.24388,580.23694,674.389-94,254.61-86,575.26779,502.38596,824.37184,843.21785,550.01572,271.41280,504.61871,668.73786,966.25162,210.72969,161.73266,627.03659,091.23468,643.83865,782.58950,574.19644,843.65441,396.517
Bedrijfsresultaat 19,343.92426,045.55710,254.81514,782.158-10,712.05-18,936.0572,722.814-44,620.659-9,247.433-40,072.055-37,137.881134,045.618-49,937.834-65,081.34575,931.762-53,509.538-63,035.72-57,836.009-65,117.557-66,024.711-50,492.538-38,408.42475,666.937
Bedrijfsresultaat ratio 0.1420.1940.090.117-0.119-0.2460.045-0.711-0.104-0.75-0.9030.581-2.085-2.7150.542-3.327-16.068-28.002-16.579-331.66-618.332-5.9020.646
Totaal overige inkomsten en kosten netto -9,843.4-2,250.031-2,537.497-11,268.545-9,112.833-6,116.38820,162.199-1,928.497-7,372.256-4,218.1512,128.067-81,364.5972,035.751-1,181.32753,430.0642,164.98-9.644-1,594.618-921.224-75.862-694.893-3,753.854-3,566.826
Inkomen voor belasting 9,500.52423,795.52613,223.00613,551.36-19,824.882-25,052.445-2,494.049-46,549.153-16,619.692-44,290.208-35,009.81152,681.02-44,503.623-66,262.672129,361.823-51,344.558-63,045.365-59,430.627-66,088.78-66,100.574-50,236.863-42,162.27972,100.11
Inkomen voor belasting ratio 0.070.1780.1160.107-0.219-0.325-0.041-0.742-0.187-0.829-0.8510.228-1.858-2.7640.924-3.193-16.071-28.774-16.826-332.041-615.201-6.4780.616
Belastingkosten 3,192.029-762.535-1,939.557-5,232.056-1,410.797-1,710.098-125.323-2,689.737-1,657.1771,113.174195.7545,554.122-229.451735.057371.1796,770.01628.736199.131506.401-13,032.6196.792474.501-1,194.29
Nettowinst 9,654.74928,135.89412,832.0746,759.789-13,931.565-23,342.347-2,368.726-43,859.416-14,962.515-45,403.382-35,205.56547,126.898-44,274.172-66,997.729128,990.644-58,114.574-63,074.101-59,629.757-66,595.182-53,067.955-50,243.655-42,636.7872,100.11
Nettowinstmarge 0.0710.210.1130.053-0.154-0.303-0.039-0.699-0.168-0.85-0.8560.204-1.849-2.7950.921-3.613-16.078-28.871-16.955-266.575-615.285-6.5510.616
WPA (Winst Per Aandeel) 123.28359163.8686.32-177.9-298.06-30.25-560.05-191.06-580-450601.4-565.35-855.511,647-742.08-850-913-1,025-816.45-773-6561,109
Verwaterde WPA 123.28359.27163.8686.32-177.9-298.06-30.25-560.05-191.06-579.77-449.55601.4-565-8551,647-742.08-850-913-1,025-816.45-773-6561,109
EBITDA 120,069.17130,370.85614,662.80819,274.002-8,535.236-17,196.777-3,432.135-41,224.755-6,832.675-38,291.737-34,057.053139,695.438-41,347.258-63,110.57178,762.418-47,583.561-58,980.485-55,038.193-62,986.445-63,324.246-48,199.248-37,940.45377,071.09
EBITDA ratio 0.8790.2270.1280.1520.9250.8780.1-0.715-0.077-0.631-0.6720.232-1.557-2.6210.946-3.086-15.012-26.642-16.036-317.709-589.907-5.830.648